125I-insulin binding to circulating erythrocytes, monocytes and cultured fibroblasts in non-obese patients with polycystic ovarian disease.

S. Mahabeer, C. Naidoo, R. J. Norman, I. Jialal, T. Govender, R. Haneef, R. Dunn, S. M. Joubert

Research output: Contribution to journalArticle

Abstract

The insulin receptor status of circulating erythrocytes, monocytes and cultured fibroblasts were studied in non-obese Indian women with polycystic ovarian disease (PCOD) with no clinical evidence of acanthosis nigricans and age, height and weight matched reference subjects. The women with polycystic ovaries had decreased mean maximum specific binding to erythrocytes (PCOD 7.4 +/- 0.6%, normal women 11.5 +/- 0.3%; p less than 0.0001) and monocytes (PCOD 2.4 +/- 0.3%, normal women 4.1 +/- 0.4%; p less than 0.003) when compared to the normal women. This decreased binding was attributed to a change in both receptor number and affinity. 125I-insulin binding to cultured fibroblasts revealed similar mean maximum specific binding and affinity values in both groups studied. Although further work is necessary to exclude genetic or post-receptor defects, it is likely that an environmental factor is implicated in the decreased 125I-insulin binding to erythrocytes and monocytes.

Original languageEnglish (US)
Pages (from-to)139-144
Number of pages6
JournalDiabetes Research
Volume13
Issue number3
StatePublished - Mar 1990
Externally publishedYes

Fingerprint

Ovarian Diseases
Monocytes
Fibroblasts
Erythrocytes
Insulin
Acanthosis Nigricans
Insulin Receptor
Ovary
Weights and Measures

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine

Cite this

Mahabeer, S., Naidoo, C., Norman, R. J., Jialal, I., Govender, T., Haneef, R., ... Joubert, S. M. (1990). 125I-insulin binding to circulating erythrocytes, monocytes and cultured fibroblasts in non-obese patients with polycystic ovarian disease. Diabetes Research, 13(3), 139-144.

125I-insulin binding to circulating erythrocytes, monocytes and cultured fibroblasts in non-obese patients with polycystic ovarian disease. / Mahabeer, S.; Naidoo, C.; Norman, R. J.; Jialal, I.; Govender, T.; Haneef, R.; Dunn, R.; Joubert, S. M.

In: Diabetes Research, Vol. 13, No. 3, 03.1990, p. 139-144.

Research output: Contribution to journalArticle

Mahabeer, S, Naidoo, C, Norman, RJ, Jialal, I, Govender, T, Haneef, R, Dunn, R & Joubert, SM 1990, '125I-insulin binding to circulating erythrocytes, monocytes and cultured fibroblasts in non-obese patients with polycystic ovarian disease.', Diabetes Research, vol. 13, no. 3, pp. 139-144.
Mahabeer, S. ; Naidoo, C. ; Norman, R. J. ; Jialal, I. ; Govender, T. ; Haneef, R. ; Dunn, R. ; Joubert, S. M. / 125I-insulin binding to circulating erythrocytes, monocytes and cultured fibroblasts in non-obese patients with polycystic ovarian disease. In: Diabetes Research. 1990 ; Vol. 13, No. 3. pp. 139-144.
@article{558ea20b25d64d268752d269f49be9e5,
title = "125I-insulin binding to circulating erythrocytes, monocytes and cultured fibroblasts in non-obese patients with polycystic ovarian disease.",
abstract = "The insulin receptor status of circulating erythrocytes, monocytes and cultured fibroblasts were studied in non-obese Indian women with polycystic ovarian disease (PCOD) with no clinical evidence of acanthosis nigricans and age, height and weight matched reference subjects. The women with polycystic ovaries had decreased mean maximum specific binding to erythrocytes (PCOD 7.4 +/- 0.6{\%}, normal women 11.5 +/- 0.3{\%}; p less than 0.0001) and monocytes (PCOD 2.4 +/- 0.3{\%}, normal women 4.1 +/- 0.4{\%}; p less than 0.003) when compared to the normal women. This decreased binding was attributed to a change in both receptor number and affinity. 125I-insulin binding to cultured fibroblasts revealed similar mean maximum specific binding and affinity values in both groups studied. Although further work is necessary to exclude genetic or post-receptor defects, it is likely that an environmental factor is implicated in the decreased 125I-insulin binding to erythrocytes and monocytes.",
author = "S. Mahabeer and C. Naidoo and Norman, {R. J.} and I. Jialal and T. Govender and R. Haneef and R. Dunn and Joubert, {S. M.}",
year = "1990",
month = "3",
language = "English (US)",
volume = "13",
pages = "139--144",
journal = "Diabetes Research",
issn = "0265-5985",
number = "3",

}

TY - JOUR

T1 - 125I-insulin binding to circulating erythrocytes, monocytes and cultured fibroblasts in non-obese patients with polycystic ovarian disease.

AU - Mahabeer, S.

AU - Naidoo, C.

AU - Norman, R. J.

AU - Jialal, I.

AU - Govender, T.

AU - Haneef, R.

AU - Dunn, R.

AU - Joubert, S. M.

PY - 1990/3

Y1 - 1990/3

N2 - The insulin receptor status of circulating erythrocytes, monocytes and cultured fibroblasts were studied in non-obese Indian women with polycystic ovarian disease (PCOD) with no clinical evidence of acanthosis nigricans and age, height and weight matched reference subjects. The women with polycystic ovaries had decreased mean maximum specific binding to erythrocytes (PCOD 7.4 +/- 0.6%, normal women 11.5 +/- 0.3%; p less than 0.0001) and monocytes (PCOD 2.4 +/- 0.3%, normal women 4.1 +/- 0.4%; p less than 0.003) when compared to the normal women. This decreased binding was attributed to a change in both receptor number and affinity. 125I-insulin binding to cultured fibroblasts revealed similar mean maximum specific binding and affinity values in both groups studied. Although further work is necessary to exclude genetic or post-receptor defects, it is likely that an environmental factor is implicated in the decreased 125I-insulin binding to erythrocytes and monocytes.

AB - The insulin receptor status of circulating erythrocytes, monocytes and cultured fibroblasts were studied in non-obese Indian women with polycystic ovarian disease (PCOD) with no clinical evidence of acanthosis nigricans and age, height and weight matched reference subjects. The women with polycystic ovaries had decreased mean maximum specific binding to erythrocytes (PCOD 7.4 +/- 0.6%, normal women 11.5 +/- 0.3%; p less than 0.0001) and monocytes (PCOD 2.4 +/- 0.3%, normal women 4.1 +/- 0.4%; p less than 0.003) when compared to the normal women. This decreased binding was attributed to a change in both receptor number and affinity. 125I-insulin binding to cultured fibroblasts revealed similar mean maximum specific binding and affinity values in both groups studied. Although further work is necessary to exclude genetic or post-receptor defects, it is likely that an environmental factor is implicated in the decreased 125I-insulin binding to erythrocytes and monocytes.

UR - http://www.scopus.com/inward/record.url?scp=0025398085&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025398085&partnerID=8YFLogxK

M3 - Article

C2 - 2128692

AN - SCOPUS:0025398085

VL - 13

SP - 139

EP - 144

JO - Diabetes Research

JF - Diabetes Research

SN - 0265-5985

IS - 3

ER -